Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hearing01:31

Hearing

51.4K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.4K
The Cochlea01:13

The Cochlea

44.1K
The cochlea is a coiled structure in the inner ear that contains hair cells—the sensory receptors of the auditory system. Sound waves are transmitted to the cochlea by small bones attached to the eardrum called the ossicles, which vibrate the oval window that leads to the inner ear. This causes fluid in the chambers of the cochlea to move, vibrating the basilar membrane.
44.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

Ear and hearing·2026
Same author

Exploring and Overcoming Challenges for Efficient Audiological Testing in Children Under 5 Years of Age-Screening with Otoacoustic Emissions.

Audiology research·2026
Same author

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

Drug delivery·2026
Same author

Effects of hearing intervention on physical function: A secondary analysis of the ACHIEVE study.

PloS one·2026
Same author

Patient-Centered Hearing Intervention Leads to Positive Outcomes: The Association of Hearing Technology With Daily Hearing Aid Usage and Listening Goals in the Aging and Cognitive Health Evaluation in Elders Study.

American journal of audiology·2026
Same author

Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider Survey.

Cancer medicine·2026

Related Experiment Video

Updated: May 17, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.3K

What's New in Ototoxicity Management?

Katharine A Fernandez1, Angela Garinis2,3, Kristin Knight4

  • 1National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD.

Perspectives of the ASHA Special Interest Groups
|March 31, 2025
PubMed
Summary
This summary is machine-generated.

Proactive ototoxicity management (OtoM) strategies protect hearing and vestibular health from damaging medications and chemicals. Wider adoption of OtoM services is encouraged to minimize risks and manage auditory changes.

More Related Videos

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

17.2K
A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
09:18

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection

Published on: March 8, 2017

13.1K

Related Experiment Videos

Last Updated: May 17, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.3K
The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

17.2K
A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
09:18

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection

Published on: March 8, 2017

13.1K

Area of Science:

  • Audiology
  • Occupational Health
  • Toxicology

Background:

  • Ototoxic medications and workplace chemicals pose risks to hearing and vestibular health.
  • Permanent injury can result from exposure to ototoxic agents.
  • Current management strategies require broader implementation.

Purpose of the Study:

  • To summarize viewpoints on integrating ototoxicity management (OtoM) into clinical practice.
  • To identify tools and considerations for supporting patients undergoing OtoM.
  • To encourage widespread adoption of improved OtoM services for at-risk individuals.

Main Methods:

  • Discussion among members of the International Ototoxicity Management Group.
  • Summarization of expert viewpoints on OtoM integration.
  • Review of current practices and future needs in ototoxicity management.

Main Results:

  • OtoM strategies aim to minimize exposure, prevent symptom onset, and monitor auditory/vestibular changes.
  • Expert consensus was reached on integrating OtoM into routine clinical practice.
  • Key considerations for patient and family support were identified.

Conclusions:

  • The audiology field needs to expand universal guidelines for mitigating, detecting, and managing ototoxicity.
  • A recent therapeutic drug offers protection but is limited to a specific pediatric population.
  • Ototoxicity from other agents and in diverse patient groups remains a significant concern.